Hims & Hers Health, Inc.

NYSE:HIMS 株式レポート

時価総額:US$5.3b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Hims & Hers Health 過去の業績

過去 基準チェック /06

Hims & Hers Healthは7.8%の年平均成長率で業績を伸ばしているが、Healthcare業界はgrowingで5.6%毎年増加している。売上は成長しており、年平均54.8%の割合である。

主要情報

7.8%

収益成長率

49.4%

EPS成長率

Healthcare 業界の成長8.5%
収益成長率54.8%
株主資本利益率-0.7%
ネット・マージン-0.2%
前回の決算情報31 Mar 2024

最近の業績更新

Recent updates

Why Investors Shouldn't Be Surprised By Hims & Hers Health, Inc.'s (NYSE:HIMS) 70% Share Price Surge

Jun 19
Why Investors Shouldn't Be Surprised By Hims & Hers Health, Inc.'s (NYSE:HIMS) 70% Share Price Surge

Hims & Hers: The Undervalued Gem Poised For Growth

Jun 18

Beyond The Marketing Machine: Why Hims & Hers Stock Might Be Vulnerable

Jun 10

Hims & Hers Health, Inc.'s (NYSE:HIMS) CEO Compensation Is Looking A Bit Stretched At The Moment

May 31
Hims & Hers Health, Inc.'s (NYSE:HIMS) CEO Compensation Is Looking A Bit Stretched At The Moment

Hims & Hers: Soaring On Access To Compounded GLP-1 Drugs, Further Volatility Ahead

May 21

Hims & Hers Health: An Unforced Error

May 06

Hims & Hers Health, Inc. (NYSE:HIMS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing

May 04
Hims & Hers Health, Inc. (NYSE:HIMS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing

Hims & Hers Health: Becoming A Market Leader Within The Growing Digital Health Industry

Apr 24

Hims & Hers Health: Strong Prospects But Weak Business Model Consolidation

Apr 05

Hims & Hers: 5 Reasons Why This Is A Phenomenal Long-Term Growth Stock

Mar 21

Pills Pay The Bills: Mini Deep Dive On Hims & Hers Health

Mar 12

Investors Appear Satisfied With Hims & Hers Health, Inc.'s (NYSE:HIMS) Prospects As Shares Rocket 49%

Feb 28
Investors Appear Satisfied With Hims & Hers Health, Inc.'s (NYSE:HIMS) Prospects As Shares Rocket 49%

Hims & Hers: Turning The Profitability Corner And Returning 28%

Feb 25

Hims & Hers Health: No Clear Moat Besides First Mover Advantage

Jan 23

Hims & Hers Health: Unleashing Macro Momentum - Investing In Growth At A Higher Multiple

Jan 10

Investors Still Waiting For A Pull Back In Hims & Hers Health, Inc. (NYSE:HIMS)

Jan 07
Investors Still Waiting For A Pull Back In Hims & Hers Health, Inc. (NYSE:HIMS)

Hims & Hers Health Q3: The Cheapest Growth Stock Around

Dec 14

Hims & Hers Health: What Would The Author Of 100 Baggers Say?

Nov 30

Hims & Hers: The Most Undervalued Small Cap Stock I See

Nov 08

Hims & Hers: A Promising Company With Resolvable Challenges

Nov 02

Hims & Hers: Specialization Is The Secret To Great Growth

Oct 25

Hims & Hers Health: Can't Get Much Better

Sep 25

The Market Is Wrong On Hims & Hers Health

Sep 18

Hims & Hers: The Current Weakness Creates A Buying Opportunity

Aug 15

Hims & Hers Health: Giving Investors Another Bite At The Apple

Aug 01

Hims & Hers Health, Inc.'s (NYSE:HIMS) Price In Tune With Revenues

Jul 21
Hims & Hers Health, Inc.'s (NYSE:HIMS) Price In Tune With Revenues

Hims & Hers Health: Expect Strong EBITDA Growth As Revenue Growth Remains Strong

Jul 13

Hims & Hers Health: Double-Edged Sword

Jul 02

Hims & Hers: More Transparency Could Help The Stock

Jun 09

Hims & Hers Health (NYSE:HIMS) Is In A Strong Position To Grow Its Business

Apr 19
Hims & Hers Health (NYSE:HIMS) Is In A Strong Position To Grow Its Business

Are Investors Undervaluing Hims & Hers Health, Inc. (NYSE:HIMS) By 41%?

Mar 30
Are Investors Undervaluing Hims & Hers Health, Inc. (NYSE:HIMS) By 41%?

Him & Hers Health Q4 2022 Earnings Preview

Feb 24

Hims & Hers spikes as Jefferies upgrades ahead of 2023 guidance

Feb 09

収支内訳

Hims & Hers Health の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NYSE:HIMS 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
31 Mar 24959-274353
31 Dec 23872-2469348
30 Sep 23793-3663943
30 Jun 23711-4758139
31 Mar 23616-5951434
31 Dec 22527-6644629
30 Sep 22444-8638126
30 Jun 22374-8332435
31 Mar 22321-7328128
31 Dec 21272-10828922
30 Sep 21229-8225017
30 Jun 21196-722170
31 Mar 21171-631860
31 Dec 20149-1811311
30 Sep 20132-251170
30 Jun 20112-381140
31 Mar 2095-581170
31 Dec 1983-721190
31 Dec 1827-75840

質の高い収益: HIMSは現在利益が出ていません。

利益率の向上: HIMSは現在利益が出ていません。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: HIMSは利益を出していないが、過去 5 年間で年間7.8%の割合で損失を削減してきた。

成長の加速: HIMSの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: HIMSは利益が出ていないため、過去 1 年間の収益成長をHealthcare業界 ( 15.1% ) と比較することは困難です。


株主資本利益率

高いROE: HIMSは現在利益が出ていないため、自己資本利益率 ( -0.68% ) はマイナスです。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘